Share

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Stocks

CN¥ 13.64Last Updated 30.04.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

CN¥ 976.82M

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 13.64
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. engages in the smart grid and healthcare business in China. It is involved in research and development, manufacturing, sales, and service of products related to intelligent recording and analysis of power systems, time synchronization, substation integrated automation, and distribution network automation. The company offers power fault recording devices, time synchronization devices, substation integrated automation devices, intelligent distribution network equipment, smart grid testing instruments, etc., as well as medical informatization and in-vitro diagnosis related products. Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. was founded in 2001 and is based in Wuhan, China.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks